NUHS@Home, National University Health System, Singapore, Singapore; Division of Advanced Internal Medicine, Department of Medicine, National University Hospital, Singapore, Singapore.
Institute of Operations Research and Analytics, National University of Singapore, Singapore, Singapore.
J Am Med Dir Assoc. 2024 Sep;25(9):105154. doi: 10.1016/j.jamda.2024.105154. Epub 2024 Jul 14.
This study aimed to compare clinical and utilization outcomes between home-first and hospital-first models of care in the operation of a hospital-at-home (HaH) program.
This is a retrospective cohort study in which the primary outcome was a composite of oxygenation, intensive care unit admission, and all-cause mortality and the primary utilization outcome was length of stay (hospital and home bed days).
The study sample included 1025 patients with COVID-19 admitted to an HaH program in Singapore from September 23, 2021, to February 29, 2022.
Propensity score weighting and regression analysis were used to adjust for confounding between both groups.
There was no significant difference in the odds of occurrence of the primary outcome between the home-first and hospital-first groups (OR, 1.17; 95% CI, 0.44-3.10). Home-first patients had a shorter length of stay by an average of 2.02 (95% CI, 1.10-2.93) days with no statistically significant difference in clinical outcomes compared with hospital-first patients.
Patients with COVID-19 suitable for HaH should be considered for direct admission to HaH without need for an initial hospital stay.
本研究旨在比较居家优先和医院优先两种护理模式在医院居家(HaH)项目运作中的临床和利用结果。
这是一项回顾性队列研究,主要结局是氧合、重症监护病房入院和全因死亡率的综合指标,主要利用结局是住院时间(医院和家庭床位天数)。
研究样本包括 2021 年 9 月 23 日至 2022 年 2 月 29 日期间在新加坡接受 HaH 项目治疗的 1025 例 COVID-19 患者。
采用倾向评分加权和回归分析调整两组之间的混杂因素。
居家优先组和医院优先组主要结局的发生几率无显著差异(OR,1.17;95%CI,0.44-3.10)。与医院优先组相比,居家优先组的平均住院时间缩短了 2.02 天(95%CI,1.10-2.93),但临床结局无统计学差异。
适合 HaH 的 COVID-19 患者应考虑直接入住 HaH,无需初始住院。